Nonketotic hyperglycinemia

From WikiMD's Wellness Encyclopedia

Nonketotic Hyperglycinemia Nonketotic hyperglycinemia (NKH) is a rare genetic disorder characterized by an accumulation of glycine in the body due to a defect in the glycine cleavage system. This condition leads to severe neurological symptoms and developmental delays.

Pathophysiology[edit | edit source]

Nonketotic hyperglycinemia is caused by mutations in the genes encoding the glycine cleavage system, which is responsible for breaking down glycine. The system consists of four protein components: P-protein, T-protein, H-protein, and L-protein. Mutations in the genes for these proteins, particularly the GLDC and AMT genes, lead to the accumulation of glycine in the central nervous system and other tissues.

Clinical Presentation[edit | edit source]

Patients with NKH typically present in the neonatal period with:

In some cases, symptoms may appear later in infancy or childhood. The severity of the condition can vary, with some patients experiencing milder forms of the disease.

Diagnosis[edit | edit source]

Diagnosis of nonketotic hyperglycinemia is based on:

  • Elevated glycine levels in the blood and cerebrospinal fluid (CSF)
  • CSF-to-plasma glycine ratio
  • Genetic testing to identify mutations in the GLDC or AMT genes

Treatment[edit | edit source]

There is currently no cure for NKH, and treatment focuses on managing symptoms. Options include:

  • Anticonvulsants for seizure control
  • Sodium benzoate to reduce glycine levels
  • Supportive therapies such as physical and occupational therapy

Prognosis[edit | edit source]

The prognosis for individuals with nonketotic hyperglycinemia varies. Severe forms of the disease can lead to significant neurological impairment and early mortality, while milder forms may allow for longer survival with varying degrees of developmental delay.

Research and Future Directions[edit | edit source]

Research is ongoing to better understand the genetic and biochemical basis of NKH and to develop more effective treatments. Gene therapy and enzyme replacement therapy are potential future avenues for treatment.

See Also[edit | edit source]

External Links[edit | edit source]

NIH genetic and rare disease info[edit source]

Nonketotic hyperglycinemia is a rare disease.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD